---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-24-000143"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T01:58:29.479419+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q3 revenue $770.4M (+14.3% YoY); adjusted EBITDA $128.6M (+21.9%)

## Summary
- Revenue $770.4M, +14.3% YoY; same-facility revenue +4.2% on 3.7% case growth.
- Adjusted EBITDA $128.6M, +21.9% YoY; margin 16.7%, expanding 100 bps.
- Net loss attributable to Surgery Partners was $31.7M.
- FY 2024 outlook reaffirmed: revenue >$3.075B, adjusted EBITDA >$508M.
- Cash $221.8M, revolver capacity $595.8M; total net debt/EBITDA 3.8x.

## SEC filing metadata
- accession: 0001638833-24-000143
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000143/0001638833-24-000143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000143/sgry-20241112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-24-000143
- JSON: https://secwatch.observer/filing/0001638833-24-000143.json
- Plain text: https://secwatch.observer/filing/0001638833-24-000143.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.